The Application of Clinical Genetics Dovepress Influence of Oncogenic Transcription Factors on Chromatin Conformation and Implications in Prostate Cancer

License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php The Application of Clinical Genetics 2014:7 81–91 The Application of Clinical Genetics Dovepress

[1]  P. Knoepfler,et al.  Histone H3.3 mutations: a variant path to cancer. , 2013, Cancer cell.

[2]  Kristian Helin,et al.  Chromatin proteins and modifications as drug targets , 2013, Nature.

[3]  Yan Li,et al.  A high-resolution map of three-dimensional chromatin interactome in human cells , 2013, Nature.

[4]  Jindan Yu,et al.  ERG is a critical regulator of Wnt/LEF1 signaling in prostate cancer. , 2013, Cancer research.

[5]  S. Dhanasekaran,et al.  The long noncoding RNA SChLAP1 promotes aggressive prostate cancer and antagonizes the SWI/SNF complex , 2013, Nature Genetics.

[6]  Wendy A Bickmore,et al.  The spatial organization of the human genome. , 2013, Annual review of genomics and human genetics.

[7]  M. Rosenfeld,et al.  LncRNA-Dependent Mechanisms of Androgen Receptor-regulated Gene Activation Programs , 2013, Nature.

[8]  Chenguang Wang,et al.  Targeting epigenetics for the treatment of prostate cancer: recent progress and future directions. , 2013, Seminars in oncology.

[9]  T. H. van der Kwast,et al.  Altered DNA Methylation Landscapes of Polycomb-Repressed Loci Are Associated with Prostate Cancer Progression and ERG Oncogene Expression in Prostate Cancer , 2013, Clinical Cancer Research.

[10]  A. Göndör.  Dynamic chromatin loops bridge health and disease in the nuclear landscape. , 2013, Seminars in cancer biology.

[11]  Yan Liu,et al.  EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations , 2012, Nature.

[12]  J. Dekker,et al.  The long-range interaction landscape of gene promoters , 2012, Nature.

[13]  Nadav S. Bar,et al.  Landscape of transcription in human cells , 2012, Nature.

[14]  Mark A. Rubin,et al.  Oncogenic transcription factors as master regulators of chromatin topology , 2012, Cell cycle.

[15]  Edwin Cheung,et al.  A transcriptional repressor co‐regulatory network governing androgen response in prostate cancers , 2012, The EMBO journal.

[16]  M. Rubin,et al.  Oncogene-mediated alterations in chromatin conformation , 2012, Proceedings of the National Academy of Sciences.

[17]  J. Sedat,et al.  Spatial partitioning of the regulatory landscape of the X-inactivation centre , 2012, Nature.

[18]  Benjamin J. Raphael,et al.  The Mutational Landscape of Lethal Castrate Resistant Prostate Cancer , 2016 .

[19]  Jesse R. Dixon,et al.  Topological Domains in Mammalian Genomes Identified by Analysis of Chromatin Interactions , 2012, Nature.

[20]  Martin Dugas,et al.  Inhibition of the LSD1 (KDM1A) demethylase reactivates the all-trans-retinoic acid differentiation pathway in acute myeloid leukemia , 2012, Nature Medicine.

[21]  Jun Liu,et al.  Cooperation between Polycomb and androgen receptor during oncogenic transformation. , 2012, Genome research.

[22]  L. Fazli,et al.  Histone H2A.Z prepares the prostate specific antigen (PSA) gene for androgen receptor-mediated transcription and is upregulated in a model of prostate cancer progression. , 2012, Cancer letters.

[23]  K. Nephew,et al.  Androgen receptor-driven chromatin looping in prostate cancer , 2011, Trends in Endocrinology & Metabolism.

[24]  P. Nelson,et al.  Androgen receptor gene expression in prostate cancer is directly suppressed by the androgen receptor through recruitment of lysine-specific demethylase 1. , 2011, Cancer cell.

[25]  Zhaohui S. Qin,et al.  Coordinated regulation of polycomb group complexes through microRNAs in cancer. , 2011, Cancer cell.

[26]  Qianben Wang,et al.  Phospho‐MED1‐enhanced UBE2C locus looping drives castration‐resistant prostate cancer growth , 2011, The EMBO journal.

[27]  J. Issa,et al.  Epigenetics in cancer: what's the future? , 2011, Oncology.

[28]  Eric S. Lander,et al.  The genomic complexity of primary human prostate cancer , 2010, Nature.

[29]  David A. Orlando,et al.  Mediator and Cohesin Connect Gene Expression and Chromatin Architecture , 2010, Nature.

[30]  Martin J. Aryee,et al.  Androgen-induced TOP2B mediated double strand breaks and prostate cancer gene rearrangements , 2010, Nature Genetics.

[31]  Francesca Demichelis,et al.  Rearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanoma , 2010, Nature Medicine.

[32]  S. Varambally,et al.  The neuronal repellent SLIT2 is a target for repression by EZH2 in prostate cancer , 2010, Oncogene.

[33]  Zhaohui S. Qin,et al.  An integrated network of androgen receptor, polycomb, and TMPRSS2-ERG gene fusions in prostate cancer progression. , 2010, Cancer cell.

[34]  A. Malek,et al.  ETS Transcription Factors Control Transcription of EZH2 and Epigenetic Silencing of the Tumor Suppressor Gene Nkx3.1 in Prostate Cancer , 2010, PloS one.

[35]  R. Ghosh,et al.  Chromatin higher-order structure and dynamics. , 2010, Cold Spring Harbor perspectives in biology.

[36]  Howard Y. Chang,et al.  Long noncoding RNA HOTAIR reprograms chromatin state to promote cancer metastasis , 2010, Nature.

[37]  Clifford A. Meyer,et al.  Nucleosome Dynamics Define Transcriptional Enhancers , 2010, Nature Genetics.

[38]  Rameen Beroukhim,et al.  An oncogene–tumor suppressor cascade drives metastatic prostate cancer by coordinately activating Ras and nuclear factor-κB , 2010, Nature Medicine.

[39]  Jie Zhang,et al.  Nuclear Receptor-Induced Chromosomal Proximity and DNA Breaks Underlie Specific Translocations in Cancer , 2009, Cell.

[40]  S. Varambally,et al.  Induced Chromosomal Proximity and Gene Fusions in Prostate Cancer , 2009, Science.

[41]  C. Cooper,et al.  ETS gene fusions in prostate cancer , 2009, Nature Reviews Urology.

[42]  Steven Henikoff,et al.  Labile H3.3+H2A.Z nucleosomes mark 'nucleosome-free regions' , 2009, Nature Genetics.

[43]  M. Gerstein,et al.  N-myc downstream regulated gene 1 (NDRG1) is fused to ERG in prostate cancer. , 2009, Neoplasia.

[44]  Clifford A. Meyer,et al.  Androgen Receptor Regulates a Distinct Transcription Program in Androgen-Independent Prostate Cancer , 2009, Cell.

[45]  M. Lupien,et al.  Cistromics of hormone-dependent cancer. , 2009, Endocrine-related cancer.

[46]  G. Jenster,et al.  Two unique novel prostate-specific and androgen-regulated fusion partners of ETV4 in prostate cancer. , 2008, Cancer research.

[47]  Clifford A. Meyer,et al.  FoxA1 Translates Epigenetic Signatures into Enhancer-Driven Lineage-Specific Transcription , 2008, Cell.

[48]  R. Shah,et al.  Role of the TMPRSS2-ERG gene fusion in prostate cancer. , 2008, Neoplasia.

[49]  W. Weichert,et al.  Histone deacetylases 1, 2 and 3 are highly expressed in prostate cancer and HDAC2 expression is associated with shorter PSA relapse time after radical prostatectomy , 2008, British Journal of Cancer.

[50]  D. Ghosh,et al.  A polycomb repression signature in metastatic prostate cancer predicts cancer outcome. , 2007, Cancer research.

[51]  S. Dhanasekaran,et al.  Integrative genomics analysis reveals silencing of beta-adrenergic signaling by polycomb in prostate cancer. , 2007, Cancer cell.

[52]  K. Pienta,et al.  A hierarchical network of transcription factors governs androgen receptor-dependent prostate cancer growth. , 2007, Molecular cell.

[53]  S. Dhanasekaran,et al.  Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer , 2007, Nature.

[54]  Y Pawitan,et al.  TMPRSS2:ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort , 2007, Oncogene.

[55]  S. Berger.  The complex language of chromatin regulation during transcription , 2007, Nature.

[56]  A. D. De Marzo,et al.  Abnormal DNA methylation, epigenetics, and prostate cancer. , 2007, Frontiers in bioscience : a journal and virtual library.

[57]  Bing Li,et al.  The Role of Chromatin during Transcription , 2007, Cell.

[58]  T. Kouzarides.  Chromatin Modifications and Their Function , 2007, Cell.

[59]  Zohar Yakhini,et al.  Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer , 2007, Nature Genetics.

[60]  B. Steensel,et al.  Nuclear organization of active and inactive chromatin domains uncovered by chromosome conformation capture–on-chip (4C) , 2006, Nature Genetics.

[61]  O. Kallioniemi,et al.  TMPRSS2 fusions with oncogenic ETS factors in prostate cancer involve unbalanced genomic rearrangements and are associated with HDAC1 and epigenetic reprogramming. , 2006, Cancer research.

[62]  Kevin Struhl,et al.  Asf1 mediates histone eviction and deposition during elongation by RNA polymerase II. , 2006, Molecular cell.

[63]  J. Tchinda,et al.  Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. , 2006, Science.

[64]  B. Maier-Davis,et al.  Chromatin remodeling by nucleosome disassembly in vitro. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[65]  R. Roeder,et al.  Mechanism of Polymerase II Transcription Repression by the Histone Variant macroH2A , 2006, Molecular and Cellular Biology.

[66]  B. Cairns,et al.  Genome-Wide Dynamics of Htz1, a Histone H2A Variant that Poises Repressed/Basal Promoters for Activation through Histone Loss , 2005, Cell.

[67]  S. Schreiber,et al.  Histone Variant H2A.Z Marks the 5′ Ends of Both Active and Inactive Genes in Euchromatin , 2005, Cell.

[68]  Antoine H. F. M. Peters,et al.  LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription , 2005, Nature.

[69]  Myles A Brown,et al.  Spatial and temporal recruitment of androgen receptor and its coactivators involves chromosomal looping and polymerase tracking. , 2005, Molecular cell.

[70]  T. Kundu,et al.  Human Histone Chaperone Nucleophosmin Enhances Acetylation-Dependent Chromatin Transcription , 2005, Molecular and Cellular Biology.

[71]  J. Hsieh,et al.  Down-regulation of Human DAB2IP Gene Expression Mediated by Polycomb Ezh2 Complex and Histone Deacetylase in Prostate Cancer* , 2005, Journal of Biological Chemistry.

[72]  Leonor Saiz,et al.  DNA looping in gene regulation: from the assembly of macromolecular complexes to the control of transcriptional noise. , 2005, Current opinion in genetics & development.

[73]  Sue Biggins,et al.  Histone variants: deviants? , 2005, Genes & development.

[74]  K. Luger,et al.  Nucleosome Assembly Protein 1 Exchanges Histone H2A-H2B Dimers and Assists Nucleosome Sliding* , 2005, Journal of Biological Chemistry.

[75]  J. Tyler,et al.  Chromatin disassembly mediated by the histone chaperone Asf1 is essential for transcriptional activation of the yeast PHO5 and PHO8 genes. , 2004, Molecular cell.

[76]  Stuart H. Orkin,et al.  The SWI/SNF complex — chromatin and cancer , 2004, Nature Reviews Cancer.

[77]  Wei-Hua Wu,et al.  ATP-Driven Exchange of Histone H2AZ Variant Catalyzed by SWR1 Chromatin Remodeling Complex , 2004, Science.

[78]  Andrew Flaus,et al.  Histone H2A/H2B dimer exchange by ATP-dependent chromatin remodeling activities. , 2003, Molecular cell.

[79]  Qianben Wang,et al.  A Coregulatory Role for the TRAP-Mediator Complex in Androgen Receptor-mediated Gene Expression* , 2002, The Journal of Biological Chemistry.

[80]  S. Dhanasekaran,et al.  The polycomb group protein EZH2 is involved in progression of prostate cancer , 2002, Nature.

[81]  Roy Riblet,et al.  Subnuclear Compartmentalization of Immunoglobulin Loci During Lymphocyte Development , 2002, Science.

[82]  M. Kashlev,et al.  Nucleosome remodeling induced by RNA polymerase II: loss of the H2A/H2B dimer during transcription. , 2002, Molecular cell.

[83]  Hiroshi Kimura,et al.  Kinetics of Core Histones in Living Human Cells , 2001, The Journal of cell biology.

[84]  R. Kingston,et al.  Mechanisms of transcriptional memory , 2001, Nature Reviews Molecular Cell Biology.

[85]  T. Cremer,et al.  Chromosome territories, nuclear architecture and gene regulation in mammalian cells , 2001, Nature Reviews Genetics.

[86]  Brian D. Strahl,et al.  Role of Histone H3 Lysine 9 Methylation in Epigenetic Control of Heterochromatin Assembly , 2001, Science.

[87]  R. Kingston,et al.  Octamer Transfer and Creation of Stably Remodeled Nucleosomes by Human SWI-SNF and Its Isolated ATPases , 2000, Molecular and Cellular Biology.

[88]  Andrew Flaus,et al.  Nucleosome mobilization catalysed by the yeast SWI/SNF complex , 1999, Nature.

[89]  Peter Teague,et al.  Differences in the Localization and Morphology of Chromosomes in the Human Nucleus , 1999, The Journal of cell biology.

[90]  Roger D Kornberg,et al.  Histone Octamer Transfer by a Chromatin-Remodeling Complex , 1999, Cell.

[91]  W. Bickmore,et al.  Putting the genome on the map. , 1998, Trends in genetics : TIG.

[92]  T. Richmond,et al.  Crystal structure of the nucleosome core particle at 2.8 Å resolution , 1997, Nature.

[93]  J. Workman,et al.  Persistent Site-Specific Remodeling of a Nucleosome Array by Transient Action of the SWI/SNF Complex , 1996, Science.

[94]  J. Mcneil,et al.  Nonrandom gene organization: structural arrangements of specific pre- mRNA transcription and splicing with SC-35 domains , 1995, The Journal of cell biology.

[95]  J. Workman,et al.  Stimulation of transcription factor binding and histone displacement by nucleosome assembly protein 1 and nucleoplasmin requires disruption of the histone octamer , 1995, Molecular and cellular biology.

[96]  F S Fay,et al.  A three-dimensional view of precursor messenger RNA metabolism within the mammalian nucleus. , 1993, Science.

[97]  Jerry L. Workman,et al.  Nucleosome displacement in transcription , 1993, Cell.

[98]  V. Fried,et al.  MacroH2A, a core histone containing a large nonhistone region. , 1992, Science.

[99]  O. Witte,et al.  Tyrosine kinase activity and transformation potency of bcr-abl oncogene products. , 1990, Science.

[100]  J. Knezetic,et al.  The presence of nucleosomes on a DNA template prevents initiation by RNA polymerase II in vitro , 1986, Cell.

[101]  L. C. Lutter,et al.  Structure of nucleosome core particles of chromatin , 1977, Nature.

[102]  P. Chambon,et al.  Electron microscopic and biochemical evidence that chromatin structure is a repeating unit , 1975, Cell.

[103]  R. Kornberg.  Chromatin structure: a repeating unit of histones and DNA. , 1974, Science.

[104]  J. Rowley.  A New Consistent Chromosomal Abnormality in Chronic Myelogenous Leukaemia identified by Quinacrine Fluorescence and Giemsa Staining , 1973, Nature.

[105]  L. Burgoyne,et al.  Chromatin sub-structure. The digestion of chromatin DNA at regularly spaced sites by a nuclear deoxyribonuclease. , 1973, Biochemical and biophysical research communications.

[106]  P. Nowell,et al.  Chromosome studies on normal and leukemic human leukocytes. , 1960, Journal of the National Cancer Institute.

[107]  Mark Groudine,et al.  Functional and Mechanistic Diversity of Distal Transcription Enhancers , 2011, Cell.

[108]  R. Kornberg,et al.  RSC unravels the nucleosome. , 2001, Molecular cell.